Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 363
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT00123929 | Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer | ||
NCT04025229 | High Intensity Interval Training in Endometrial Cancer | ||
NCT05440929 | Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians | ||
NCT05828927 | enCompass Carolina: A Social Support and Coaching Program for Cancer Caregivers | ||
NCT04274465 | Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia | ||
NCT05620329 | UNC Pleural Fluid Registry | ||
NCT01751529 | Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer | ||
NCT01412229 | Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
NCT03176082 | Mailed Reminders Plus Fecal Immunochemical Testing | ||
NCT06263582 | Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya | ||
NCT03407430 | Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain | ||
NCT02564120 | North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) | ||
NCT00233974 | Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery | ||
NCT03077230 | Pre-Post Study for Supporting Appropriate Implementation of Lung Cancer Screening | ||
NCT04548648 | A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas | ||
NCT03885830 | Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients | ||
NCT04223765 | Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. | ||
NCT06480773 | Kaposi Sarcoma Chemotherapy and Research (KS-CARE) | ||
NCT00719173 | Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer | ||
NCT05498220 | Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma | ||
NCT06618274 | Effectiveness of Central Oncology Navigation and the Use of an ORN | ||
NCT03281720 | Selective Image Guided Resection of Pathologically Documented Axillary Lymph Node Metastases | ||
NCT02075320 | Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis in Patients With Known Lung Nodules | ||
NCT02139774 | Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer | ||
NCT01875666 | Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib | ||
NCT05578326 | Study of Trilaciclib and Lurbinectidin | ||
NCT01725048 | Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer | ||
NCT00519831 | Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC | ||
NCT04656873 | Immuno-Oncology Database and Bioregistry | ||
NCT00320073 | Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors | ||
NCT05630131 | ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy | ||
NCT05366166 | Pembrolizumab Plus Olaparib in LA-HNSCC | ||
NCT00448357 | Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen | ||
NCT05978557 | Brain Slice Explants to Predict Drug Response in Brain Tumors | ||
NCT03602157 | Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL | ||
NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | ||
NCT00405366 | Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer | ||
NCT00776126 | Digital Breast Tomosynthesis Preference Study | ||
NCT00257426 | Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer | ||
NCT00225420 | Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer | ||
NCT01262820 | Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab | ||
NCT04073966 | MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets | ||
NCT05743426 | Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies | ||
NCT05592665 | PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology | ||
NCT04743674 | Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment | ||
NCT04092257 | HPV-Based Screen-and-Treat Demonstration Project in Lilongwe | ||
NCT01488357 | Patient Preferences for Breast Reconstruction After Mastectomy | ||
NCT00280748 | Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer | ||
NCT03529422 | Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN | ||
NCT03785782 | ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer |